The drug now known as Treximet has been approved for sale in the USA (on the 15th of April, 2008). It’s expected to hit the shelved any time now, as a prescription medicine.
But what is Treximet (formerly Trexima)? And is it worth all the hype?
Actually, I’ve written about Treximet several times before (here for example) [...]
by James on 16 April 2007
You might have heard about Pozen’s migraine product, Trexima, which is currently under review in the USA. I know I’ve heard about it – a lot about it. I’ve written about Trexima before, more than once.
Trexima is a combination drug. Its key ingredients are sumatriptan succinate (otherwise known as Imitrex) and naproxen sodium. Both of [...]
by James on 11 February 2006
There’s a new migraine drug that will probably appear on the market in the next few months, currently called Trexima. In October, the FDA accepted the drug from GlaxoSmithKline and POZEN Inc. for review.
Strictly speaking, it’s not 100% new – it’s actually a combination of two drugs that are already on the market. The first [...]